Sign in
4

Changes in Ownership

Dermata Therapeutics, Inc. Filed Acc 0000905718-21-001110

Director bought 35,714 shares

  • Director acquired 278,291 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

HALE DAVID F · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Owned after D/I
2021-08-17 Conversion : show line 1 in the form +44,777 299,411 I
2021-08-17 Conversion : show line 2 in the form +12,195 311,606 I
2021-08-17 Conversion : show line 3 in the form +20,000 331,606 I
2021-08-17 Conversion : show line 4 in the form +174,216 505,822 I
2021-08-17 Conversion : show line 5 in the form +27,103 532,925 I
2021-08-17 Purchase : show line 6 in the form +35,714 35,714 I
Open-market purchases · 35,714 sh

Table II: Derivative

8 lines
Date Transaction Shares Owned after D/I
2021-08-17 Conversion : show line 7 in the form Series 1d Preferred Stock −302,112 0 I
2021-08-17 Conversion : show line 8 in the form Series 1a Preferred Stock −250,000 0 I
2021-08-17 Conversion : show line 9 in the form Series 1b Preferred Stock −410,000 0 I
2021-08-17 Conversion : show line 10 in the form Series 1c Preferred Stock −3,571,428 0 I
2021-08-17 Conversion : show line 11 in the form Series 1 Preferred Stock −555,622 0 I
2021-08-17 Conversion : show line 12 in the form Series 1a Warrants −62,500 0 I
2021-08-17 Conversion : show line 13 in the form Warrant to Purchase Common Stock +3,048 3,048 I
2021-08-17 Purchase : show line 14 in the form Warrant to Purchase Common Stock +35,714 35,714 I
Loading xslF345X03/dermata_fm4aug172021.xml…